Notice of Rulemaking Without Public Hearing
The Controlled Substance Board will adopt the attached rule creating CSB 2.48 relating to scheduling of Eluxadoline, without public hearing under the procedure set forth in s. 961.11(4), Stats.
Submittal of Written Comments
Comments may be submitted to Sharon Henes, Administrative Rules Coordinator, Department of Safety and Professional Services, Division of Policy Development, 1400 East Washington Avenue, Room 151, P.O. Box 8366, Madison, WI 53708-8366, or by email to DSPSAdminRules@wisconsin.gov. Comments must be received on or before April 26, 2017 to be included in the record of rule-making proceedings.
Initial Regulatory Flexibility Analysis
The proposed rule will not have an effect on small businesses, as defined under s. 227.114 (1).
Agency Small Business Regulatory Coordinator
Controlled Substances Board (CSB)